The Lipid Membrane: The Unsung Hero of Cellular Health
Authors:

Ed Kane
Founder of BodyBioIntroduction: Why Is the Cell Membrane Important for Cellular Function?
I found several pieces of my grandfather’s writing and I am so happy to share it with you - give you a peak as to why and how he started BodyBio.
At BodyBio, we believe health starts on the cellular level. Every one of your 40 trillion cells relies on a resilient, functional membrane—a lipid-based structure that defines cellular boundaries and orchestrates all intracellular activity. As my grandfather, Ed Kane, always reminded us, if you're good to your cells, your cells will be good to you.
- Jess Kane Berman
Inside the Lipid Bilayer: Why Is the Cell Membrane Important for Cellular Function
The cell membrane, also known as the lipid bilayer, is just 3 to 4.5 nanometers thick—but its influence is immeasurable. Formed by two layers of fatty acids, this barrier isn't merely passive—it’s the command center of the cell, embedded with proteins and ion channels that regulate everything from nutrient transport to immune signaling.
Imagine this: it would take 10,000 membranes stacked together to equal the thickness of a single sheet of paper. And yet, inside this ultrathin layer lies a dynamic, complex system critical to your survival.
Microtubules, Membranes, and Cellular Communication
The membrane doesn’t act alone. Within the cell, microtubules form a lattice that helps direct traffic, stabilize structures, and transmit energy and information. Thought leaders like Dr. Stuart Hameroff and physicist Sir Roger Penrose have suggested that microtubules may even play a role in consciousness through quantum wave activity.
While these ideas are still theoretical, the evidence points to a powerful synergy between the cell membrane and internal scaffolding—especially in highly specialized cells like neurons, cilia, and epithelial linings.
Essential Fatty Acids and Why the Cell Membrane Needs Them
Fatty acids are the raw materials of cellular membranes. Essential fatty acids (EFAs) like omega-3 (DHA and EPA) and omega-6 (LA and AA) are necessary for maintaining membrane fluidity and function. These nutrients cannot be synthesized by the body and must come from diet or supplementation.
When incorporated correctly, EFAs provide more than just structure—they regulate immune response, cellular signaling, and even mood. However, disruptions in fatty acid balance can cascade into a variety of degenerative disorders, including neurological decline and chronic inflammation.
Phospholipids and Energy Production: The Role of Lipids in Mitochondria
Mitochondria are the energy powerhouses of your cells. But here's the secret: without a healthy lipid membrane, they cannot function. Nobel Prize-winner Peter Mitchell’s chemiosmosis theory revealed how the membrane enables the separation of hydrogen ions across mitochondrial layers to produce ATP—the energy currency of the body.
This membrane-dependent process is vital for life. And it only works when the lipid structure is intact and energized.
Cardiolipin and Mitochondrial Efficiency
Deep within the mitochondria lies cardiolipin, a rare and specialized phospholipid found exclusively in the inner mitochondrial membrane. Its unique structure—two phospholipid heads fused into one molecule with four fatty acid tails—allows it to play a critical role in stabilizing mitochondrial enzymes, maintaining membrane curvature, and supporting efficient energy production.
But cardiolipin’s function is only as good as its building blocks. And one of the most essential fatty acids required to construct healthy cardiolipin is linoleic acid (LA)—an omega-6 fatty acid that is often misunderstood but absolutely vital to mitochondrial performance.
Linoleic Acid: The Backbone of Functional Cardiolipin
In healthy cells, linoleic acid is the preferred fatty acid incorporated into cardiolipin. This specific configuration allows cardiolipin to optimally support mitochondrial function by:
-
Enhancing the structural integrity of the inner mitochondrial membrane
-
Facilitating the organization and efficiency of the electron transport chain
-
Supporting the binding of mitochondrial enzymes like cytochrome c
-
Promoting membrane fluidity and adaptability
When LA is deficient—or replaced with inappropriate, oxidized fats—cardiolipin becomes dysfunctional. The result? A cascade of mitochondrial impairment, reduced ATP production, increased oxidative stress, and cellular fatigue. This dysfunction is strongly implicated in a range of conditions, from neurodegeneration to metabolic disease and accelerated aging.
At BodyBio, we view unoxidized, clean linoleic acid not as a villain—but as a hero in the story of energy, healing, and cellular resilience. It is a cornerstone of our Balance Oil formulation and a critical nutrient for maintaining healthy mitochondrial membranes.
By prioritizing the right form of linoleic acid, we can help ensure that cardiolipin—and the mitochondria it supports—function at their highest potential.
Phosphatidylcholine and Aging: A Critical Link
Phosphatidylcholine (PC) is the most abundant phospholipid in the outer leaflet of the cell membrane—and one of the most important for cellular function, signaling, and integrity. With two fatty acid tails and a choline head group, PC forms the structural basis of the lipid bilayer, creating a fluid, flexible environment for membrane proteins and receptors to operate.
But this crucial molecule doesn’t stay static. In healthy, youthful tissue, PC integrates highly unsaturated fatty acids (HUFAs), particularly arachidonic acid (AA) and docosahexaenoic acid (DHA), at the Sn-2 position—making the membrane highly dynamic, responsive, and capable of rapid signal transmission.
As we age, however, levels of PC decline—replaced instead by stiffer, more rigid lipids like sphingomyelin (SM) and cholesterol. This shift decreases membrane fluidity, compromises nutrient transport, slows receptor signaling, and can impair organ and tissue performance across the entire body.
Aging and PC Loss: A Universal Phenomenon
In plasma membranes with low phospholipid turnover—such as the arterial walls and aorta—research shows a dramatic reduction in the PC/SM ratio. In aging tissue, this ratio may drop sixfold, and in advanced atherosclerosis lesions, SM can make up as much as 70–80% of total membrane phospholipids.
The result? A systemic loss of cellular elasticity and function, affecting every organ system:
-
Neuronal membranes lose their ability to communicate efficiently
-
Cardiac cells lose their rhythm
-
Immune cells falter in response
-
Skin and connective tissue become less resilient
-
Mitochondria, with their own PC-rich membranes, begin to fail
This isn’t just about structure—it’s about the functional life of every cell.
The Research: PC Rejuvenates Aging Cells
In one of the most powerful demonstrations of PC’s importance, researchers Yechiel and Barenholz at Hebrew University conducted a 20-day in vitro study using rat heart myocytes. These isolated heart cells were cultured in petri dishes and divided into three groups:
-
Group A: Received egg-derived PC starting on Day 6
-
Group B: Received no PC until Day 16
-
Group C: Received PC from Day 6–11, after which it was removed
The results were remarkable.
-
Group A maintained a consistent beating rate of ~160 beats per minute throughout the 20 days.
-
Group B experienced a steep decline by Day 12, some beating as low as 20 bpm—or not at all—until PC was reintroduced on Day 16.
-
Group C, which had PC removed mid-study, also saw a decline, mirroring Group B.
When PC was restored to Groups B and C on Day 16, both recovered fully within 24 hours—resuming their original rhythm and reversing the morphological signs of cell death.
This experiment showed, not just correlation, but direct causation: PC is a vital, non-negotiable component of cellular health and longevity.
PC in the Literature
A Medline search reveals over 37,000 peer-reviewed citations on phosphatidylcholine. Among the most compelling are:
-
Cui and Howeling (2002) – Demonstrated that perturbations in PC content lead to apoptosis (programmed cell death) and necrosis, and that restoring PC re-establishes cellular homeostasis
-
Yechiel and Barenholz (1985–1986) – Showed that membrane rigidity increases with age due to declining PC and increasing SM/cholesterol
-
Yehuda et al. (1993) – Suggested the optimal ratio of omega-6 to omega-3 (80:20) in membrane phospholipids for proper neuronal signaling and remodeling
These findings are not theoretical—they form the scientific foundation for BodyBio PC, our flagship phospholipid supplement. We formulate it to restore the lipid landscape of aging membranes, with a balance of high-energy essential fatty acids to revitalize every cell, from brain to heart to mitochondria.
The Membrane as the Brain of the Cell
Dr. Bruce Lipton, a cell biologist and pioneer in epigenetics, proposed that the membrane—not the nucleus—is the true control center of the cell. The DNA may house our genetic code, but the membrane is the processor and sensor, decoding signals and initiating activity.
A damaged membrane spells immediate death for a cell. Meanwhile, cells deprived of their DNA can continue living for weeks—proof of the membrane’s vital role in life.
Lipton calls it the “mem-brain”—and with good reason. Composed of over 70% fatty acids, this lipid-rich layer is the true intelligence of the cell.
Final Thoughts: Be Good to Your Cells
From the microcosmic elegance of the lipid bilayer to the life-sustaining role of mitochondrial membranes, the health of your cells starts and ends with fat—real, bioavailable, non-oxidized fat.
This is the legacy of Ed Kane, the founder of BodyBio. His vision was clear: to help people get better, one cell at a time. His work laid the foundation for everything we do today.
At BodyBio, we remain dedicated to his pioneering science, to exploring complex health challenges, and to formulating the highest quality supplements—like BodyBio PC and Balance Oil—that support your cell membranes, your mitochondria, and your mind.
Let’s be good to our cells. They’ll pay us back—a trillion times over.
Further Reading
- Lipton BH, The Biology of Belief, Unleashing the Power of Consciousness Matter and Miracles. 2005, Mountain of Love/Elite Books, Santa Rosa, CA 95404.
- Mouritsen OJ. Life-As a Matter of Fat, The Emerging Science of Lipidomics. Berlin Heidelberg: Springer-Verlag, 2005.
- Corry B, Chung SH. Mechanisms of valence selectivity in biological ion channels. Cell Mol Life Sci. 2006 Feb;63(3):301-15.
- Rudin DO. Unpublished manuscript: The Omega Factor: Our Nutritional Missing Link, 1985, Chapter 7.p.18.
- Barenholz Y. Cholesterol and other membrane active sterols: from membrane evolution to “rafts”. Prog Lipid Res. 2002 Jan;41(1):1-5.
- Gurr MI, Harwood JL, Frayn KN. Lipid biochemistry: An Introduction 5th Edition London, UK: Blackwell Publishing, 2002, reprint 2004.
- McMullen, TPW, McElhaney RN. 1996. Physical studies of cholesterolphospholipid interactions. Curr. Opin. Colloid Interface Sci. 1:83-90.
- Mason RP et al, Chapter 6: Lipids, Health, and Behavior. 1996, Ed: Hillbrand M and Spitz RT. American Physiological Assoc Washington DC 20090.
- Sikora DM, Pettit-Kekel K, Penfield J, Merkens LS, Steiner RD. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet A. 2006 Jul 15;140(14):1511-8.
- Tierney E, Nwokoro NA, Kelley RI. Behavioral phenotype of RSH/Smith-Lemli- Opitz syndrome. Ment Retard Dev Disabil Res Rev. 2000;6(2):131-4.
- Tierney E, Bukelis I, Thompson RE, Ahmed K, Aneja A, Kratz L, Kelley RI Abnormalities of cholesterol metabolism in autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 5;141(6):666-8.
- Kelley RI. Inborn errors of cholesterol biosynthesis. Adv Pediatr. 2000;47:1-53.
- Perez-Guzman C, Vargas, MH, Quinonez, F, et al. A cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. Chest 2005; 127: 643-651.
- Graveline Duane, 2004 Lipitor®, Thief of Memory: StatinDrugs and the Misguided War on Cholesterol.
- Edwards IR, Star K, Kiuru A. Statins, neuromuscular degenerative disease and an ALS- like syndrome. Drug Saf.2007;30(6):515-25.
- Conforti A, Magro L, Moretti U, et al. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy. Drug Saf. 2006;29(12):1163-72.
- Uffe Ravnskov. 2002 The Cholesterol Myths: Exposing the Fallacy that Saturated Fat and Cholesterol Cause Heart Disease. New Trends Publishing.
- Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006 Apr 13;354(15):1601-13.
- Ascherio A. Trans fatty acids and blood lipids. Atheroscler Suppl. 2006 May;7(2):25-7.
- Zaloga GP, Harvey KA, Stillwell W, Siddiqui R. Trans fatty acids and coronary heart disease. Nutr Clin Pract. 2006 Oct;21(5):505-12.
- Crawford, Michael and Marsh, David. The Driving Force: Food, Evolution and The Future by, 1989, Harper & Row (New York).
- Binkoski AE, Kris-Etherton PM, Wilson TA, Mountain ML, Nicolosi RJ. Balance of unsaturated fatty acids is important to a cholesterol-lowering diet: J Am Diet Assoc. 2005 Jul;105(7):1080-6.
- Sato M, Yoshida S, Nagao K, Imaizumi K. Superiority of dietary safflower oil over olive oil in lowering serum cholesterol. Biosci Biotechnol Biochem. 2000 Jun;64(6):1111-7.
- Sunitha T, Manorama R, Rukmini C. Lipid profile of rats fed blends of rice bran oil in combination with sunflower and safflower oil. Plant Foods Hum Nutr. 1997;51(3):219-30.
- Gupta SV, Yamada N, Fungwe TV, Khosla P. Replacing 40% of dietary animal fat with vegetable oil is associated with lower HDL cholesterol and higher cholesterol. J Nutr. 2003 Aug;133(8):2600-6.
- Sanders TA, Oakley FR, Miller GJ, et al. Nutrition, Food Influence of n-6 versus n-3 polyunsaturated fatty acids. Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3449-60.
- Yang L, Leung KY, Cao Y, et al. Alpha-linolenic acid but not conjugated linolenic acid is hypocholesterolaemic in hamsters. Br J Nutr. 2005 Apr;93(4):433-8.
- Colin A, Reggers J, Castronovo V, Ansseau M Encephale. 2003 Jan-Feb;29(1):49-58.
- Ristic V, Ristic G. ed: Pregl. 2003 Jan-Feb;56(1-2):50-3.
- Koba K, Liu JW, Bobik E, Sugano M, Huang YS. Cholesterol supplementation attenuates the hypocholesterolemic effect of rice bran oil in rats. J Nutr. Sci. Vitaminol. 2000 Apr;46(2):58-64.
- USA TODAY Health and Behavior Cholesterol guidelines become a morality play, Posted 10/16/2004.
- Jacobs D et al. Report of the conference on low blood cholesterol: Mortality Associations. Circulation.1992 Sep;86(3):1046-60.
- Iribarren C, Jacobs DR Jr, Sidney S, Claxton AJ, Feingold KR. Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases. Epidemiol Infect. 1998 Oct;121(2):335-47.
- Volpato S, Leveille SG, Corti MC, Harris TB, Guralnik JM. .J.Am.Geriatr Soc. 2001 Sep;49(9):1142-7.
- Ives DG, Bonino P, Traven ND, Kuller LH. Morbidity and mortality in rural community-dwelling elderly with low total serum cholesterol. J Gerontol. 1993 May;48(3): M103-7.
- Schalk BW, Visser M, Deeg DJ, Bouter LM. The Longitudinal Aging Study Amsterdam. Age Ageing. 2004, May;33(3):266-7
- Obialo CI, Okonofua EC, Nzerue MC, Tayade AS, Riley LJ. Kidney Int. 1999 Sep;56(3):1058-63.
- Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL. Am J Kidney Dis. 1998 Jul;32(1):107-14.
- Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006 January 4; 116(1): 4–15.
- Funk CD. Leukotriene modifiers as potential therapeutics for cardiovascular disease. Leukotriene Nat. Rev. Drug Discov. 2005; 4:664–672. .
- Murata T, et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 1997;388:678–682. .
- García Rodríguez LA, Egan K, FitzGerald GA. Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: a drug-drug interaction? PLoS Med. 2007 May;4(5):e157.
- Sitbon O, Humbert M, Simonneau G. Primary pulmonary hypertension: Current therapy. Prog Cardiovasc Dis. 2002 Sep-Oct;45(2):115-28.
- Arnal JF, Douin-Echinard V, Tremollières F, Terrisse AD, Sié P, Payrastr B, Guery JC, Bayard F, Gourdy P. Arch Mal Coeur Vaiss. 2007 Jun-Jul;100 (6-7):554-62.
- Saldeen P, Saldeen T. Women and omega-3 Fatty acids. Obstet Gynecol Surv. 2004 Oct;59(10):722-30.
- Oviedo PJ, Hermenegildo C, Cano A. Raloxifene increases the capacity of serum to promote prostacyclin release in human endothelial cells: implication of COX-1 and COX-2. Menopause. 2004 Jul-Aug;11(4): 430-7.
- Nagaya N, et al, Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats. Circulation. 2000 Oct 17;102(16):2005-10.
- Launay D, Humbert M, Hachulla E. Pulmonary arterial hypertension and systemic sclerosis. Presse Med. 2006 Dec;35(12 Pt 2):1929-37.
- Abdelrahman M, Collin M, Thiemermann C. The Peroxisome Proliferator- Actvated Receptor- Ligand 15-Deoxy D12,14 Prostaglandin J2 Reduces the Organ Injury in Hemorrhagic Shock. Shock. 22(6):555-561, December 2004.
- Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol. 2002 Mar;23(3):144-50.
- Kim HK, Choi H. Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. Lipids. 2001 Dec;36(12):1331-6.
- Kapadia R, Yi JH, Vemuganti R. Mechanisms of anti-inflammatory and neuroprotec- tive actions of PPAR-gamma agonists. Front Biosci. 2008 Jan 1;13:1813-26.
- Salgia AD, Kosnik SD. When acetaminophen use becomes toxic. Treating acute accidental and intentional overdose.Postgrad Med. 1999 Apr;105(4):81-4, 87-90.
- Haas-Stapleton EJ, Lu Y, Hong S, Arita M, Favoreto S, Nigam S, Serhan CN, Agabian N Candida albicans Modulates Host Defense by Biosynthesizing the Pro-Resolving Mediator Resolvin E1. PLoS ONE. 2007 Dec 19;2(12):e1316.
- Serhan CN, Hong S, Gronert K, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002 Oct 21;196(8):1025-37.
- Serhan CN, Arita M, Hong S, Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids. 2004 Nov;39(11):1125-32.
- Serhan CN. Lipoxins and new lipid mediators in the resolution of inflammation. Anesthesiol Clin. 2006 Jun;24(2):341-64.
- Bannenberg GL, Aliberti J, Hong S, Sher A, Serhan C, Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis. J Exp Med. 2004 Feb 16;199(4):515-23.
- Schwab JM, Serhan CN. Lipoxins and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol. 2006 Aug;6(4):414-20.
- Attwell D, Miller B, Saantis M. Arachidonic acid as a messenger in the central nervous system. Seminars in the Neurosciences 1993;5:159-169.
- Kennedy Kreiger Peroxysomal Insititute Fatty Acid Laboratory of Johns Hopkins University, Baltimore, MD USA.
- Yiin SJ, Lin TH. Effects of metallic antioxidants on cadmium-catalyzed peroxidation of arachidonic acid Ann Clin Lab Sci. 1998 Jan-Feb;28(1):43-50.
- Kane PC, Foster JS, Braccia D, Kane E. The Detoxx Book: Detoxification of Biotoxins in Chronic Neurotoxic Syndromes. Millville, NJ USA: BodyBio, 2002
- Grandjean P, Weihe P.. Arachidonic acid status during pregnancy is associated with polychlorinated biphenyl exposure. Am J Clin Nutr. 2003 Mar;77(3):715-9.
- Bilak M, Wu L, Wang Q, Haughey N, Conant K, St Hillaire C, Andreasson K. PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann Neurol. 2004 Aug;56(2):240-8.
- McGiff JC. Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol. 1991;31:339-69.
- Wang D, DuBois RN. Measurement of eicosanoids in cancer tissues. Methods Enzymol. 2007;433:27-50.
- Koletzko B, Braun M. Arachidonic acid and early human growth: is there a relation? Ann Nutr Metab. 1991;35(3):128-31.
- Carnielli VP, Simonato M, Verlato G et al. Synthesis of long-chain polyunsaturated fatty acids in preterm newborns, etc. Am J Clin Nutr. 2007 Nov;86(5):1323-30.
- Papadimitriou A, King AJ, Jones PM, Persaud SJ. Anti-apoptotic effects of arachidonic acid and prostaglandin E2, etc. Cell Physiol Biochem. 2007;20(5):607-16.
- Das UN. Essential Fatty Acids - a Review. Curr Pharm Biotechnol. 2006 ec;7(6):467-82.
- McCullough L, Wu L, Haughey N, Liang X, et al. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci. 2004 Jan 7;24(1):257-68.
- Hennig R, Kehl T, Noor S, et al. 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene, etc. Neoplasia. 2007 Nov;9(11): 917-26.
- Harbige LS, Sharief MK. Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis. Br J Nutr. 2007 Oct;98 Suppl 1:S46-53.
- Serhan CN, Lu Y, Hong S, Yang R. Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins. Methods Enzymol. 2007;432:275-317.
- Gryglewski RJ, Panczenko B, Korbut R,et al. Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels, etc. Prostaglandins 10, 343–355 (1975).
- Tashjian AH, Voekel EF, McDonough J, Levine L. Hydrocortisone inhibits prostaglan-din production by mouse fibrosarcoma cells. Nature 258, 739–741 (1976).
- Turk J, Hughes JH, Easom RA, Wolf BA, Scharp DW, Lacy PE, McDaniel ML. Arachidonic acid metabolism and insulin secretion by isolated human pancreatic islets. Diabetes. 1988 Jul;37(7):992-6.
- Loweth AC, Scarpello JH, Morgan NG. A specific inhibitor of cytosolic phospholipase A2 activity, AACOCF3, etc. Biochem Biophys Res Commun. 1996 Jan 17;218(2):423-7.
- Ma Z, Ramanadham S, Kempe K, et al. Pancreatic Islets Express a Ca2+-independent Phospholipase A2 Enzyme, etc. J Biol Chem. 1997 Apr 25;272(17):11118-27.
- Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006 Mar;17(1):4-12.
- Fujimoto WY, Metz SA. Phasic effects of glucose, phospholipase A2, and lysophos- pholipids on insulin secretion. Endocrinology. 1987 May;120(5):1750-7.
- Hirano T, Fukuyama S, Nagano S, Takahashi T. Involvement of phospholipase A2 and arachidonic acid in cholecystokinin-8, etc. Endocrinol Jpn.1984 Oct;31(5):549-55.74.
- Metz S, VanRollins M, Strife R, et al. Lipoxygenase pathway in islet endocrine cells, etc. J Clin Invest. 1983 May; 71(5):1191-205.
- Simonsson E, Karlsson S, Ahrén B. Involvement of phospholipase A2 and arachidonic acid in cholecystokinin-8-induced insulin secretion in rat islets. Regul Pept. 1996 Sep 9;65(2):101-7.
- Tadayyon M, Green IC. Pharmacological interference with phospholipase A2 activity reveals mechanistic differences, etc. Diabete Metab. 1993 Jan-Feb;19(1):36-43.
- Zawalich W, Zawalich K. Effect of exogenous phospholipase A2 on insulin secretion from perifused rat islets. Diabetes. 1985 May;34(5):471-6.
- Yehuda S, Carasso RL. Effects of dietary fats on learning, pain threshold, thermoregulation and motor activity in rats, etc. Int J Neurosci. 1987 Feb;32(3-4):919-25.
- Yehuda S, Carasso RL. Modulation of learning, pain thresholds, and thermoregulation in the rat, etc. Proc Natl Acad Sci USA 1993; 90:10345-10349.
- Yehuda S, Carasso RL, Mostofsky DI. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 1994 Mar 11;254:1-2:193-8.
- Yehuda S, Carraso RL, Mostofsky DI. Essential fatty acid preparation (SR-3) rehabilitates learning deficits induced by AF64A and 5,7-DHT. Neuroreport. 1995 Feb 15;6:3:511-5.
- Yehuda S, Brandys Y, Blumenfeld A, Mostofsky DI. Essential fatty acid preparation reduces cholesterol and fatty acids in rat cortex. Int J Neurosci. 1996 Sep;86:3-4:249-56.
- Yehuda S, Rabinovtz S, Carasso RL, Mostofsky DI. Essential fatty acids preparation (SR-3) improves Alzheimer’s, etc. Int J Neurosci. 1996 Nov;87:3-4:141-9.
- Yehuda S, Rabinovitz S, Mostofsky DI, et al. Essential fatty acid preparation improves biochemical and cognitive functions, etc. Eur J Pharmacol 1997 Jun 5;328:1:23-9.
- Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. Fatty acids and brain peptides Peptide 1998 19:2:407-19.
- Yehuda S, Rabinovitz S, Mostofsky DI. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J Neurosci Res. 1999 Jun 15;56:6:565-70.
- Yehuda S, Rabinovitz S; Carasso RL, Mostofsky DI. Fatty acid mixture counters stress changes in cortisol, cholesterol, and impair learning. Int J Neurosci Jan 2000;101:1-4: 73-87. 98. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. The role of polyunsaturated fatty acids in restoring, etc. Neurobiol Aging. 2002 Sep-Oct;23:5:843-53.
- Yehuda S, Rabinovitz S, Mostofsky DI. Mixture of essential fatty acids lowers test anxiety. Nutr Neurosci. 2005 Aug;8(4):265-7.
- Yehuda S, Rabinovitz S, Mostofsky DI. Essential fatty acids and the brain: From infancy to aging. Neurobiol Aging. 2005 Dec;26 Suppl 1:98-102.